Log In
Print
BCIQ
Print
Print this Print this
 

CDX-301

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionFMS-like tyrosine kinase 3 ligand (FLT3LG) that is a growth factor for dendritic cells
Molecular Target FMS-like tyrosine kinase 3 ligand (FLT3LG)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard Indication Transplant (unspecified)
Indication DetailsMobilize hematopoietic stem cells in transplant patients
Regulatory Designation
Partner Celldex Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today